Authors: Tao, T Skiadopoulos, MH Davoodi, F Surman, SR Collins, PL Murphy, BR

Citation: T. Tao et al., Construction of a live-attenuated bivalent vaccine virus against human parainfluenza virus (PIV) types 1 and 2 using a recombinant PIV3 backbone, VACCINE, 19(27), 2001, pp. 3620-3631

Authors: Tao, T Davoodi, F Cho, CJ Skiadopoulos, MH Durbin, AP Collins, PL Murphy, BR

Citation: T. Tao et al., A live attenuated recombinant chimeric parainfluenza virus (PIV) candidatevaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3, VACCINE, 18(14), 2000, pp. 1359-1366

Authors: Tao, T Skiadopoulos, MH Davoodi, F Riggs, JM Collins, PL Murphy, BR

Citation: T. Tao et al., Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates, J VIROLOGY, 74(14), 2000, pp. 6448-6458

Authors: Tao, T Skiadopoulos, MH Durbin, AP Davoodi, F Collins, PL Murphy, BR

Citation: T. Tao et al., A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge, VACCINE, 17(9-10), 1999, pp. 1100-1108